June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Preventing visuocotical bilirubin induced neurological dysfunction
Author Affiliations & Notes
  • William V Good
    Smith-Kettlewell Eye Research Institute, San Francisco, CA
  • Chuan Hou
    Smith-Kettlewell Eye Research Institute, San Francisco, CA
  • Vinod Bhutani
    Department of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA
  • Anthony Norcia
    Department of Psychology, Stanford University, Stanford, CA
  • Ronald Wong
    Department of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA
  • Kathleen Lewis
    California Pacific Medical Center, San Francisco, CA
  • Terri Slagel
    California Pacific Medical Center, San Francisco, CA
  • Footnotes
    Commercial Relationships William Good, None; Chuan Hou, None; Vinod Bhutani, None; Anthony Norcia, None; Ronald Wong, None; Kathleen Lewis, None; Terri Slagel, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 542. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William V Good, Chuan Hou, Vinod Bhutani, Anthony Norcia, Ronald Wong, Kathleen Lewis, Terri Slagel; Preventing visuocotical bilirubin induced neurological dysfunction. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):542.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Controversy exists regarding the spectrum of bilirubin-induced neurologic dysfunction (BIND) in neonates, and at what level of bilirubin an infant should be treated to reduce the chances of developing BIND. The goal of this study was to compare sweep visual evoked potential (sVEP) thresholds for 3 measures of vision: contrast sensitivity (CS), vernier acuity (VA), and grating acuity (GA), to an algorithm that predicts risk of BIND based on the hour-specific bilirubin Bhutani nomogram. We hypothesized that infants at higher risk on the algorithm would show worse acuity thresholds.

Methods: 90 full-term infants were recruited at birth from the well baby nursery. None had any clinical evidence for hemolysis or other risk factors for developing jaundice. Bilirubin levels were determined by measurements of transcutaneous bilirubin (TcB), total plasma bilirubin (TB), and “free” or unbound bilirubin (UB) levels. At 6 and 12 mos of age, VA, GA, and CS thresholds were measured by a masked observer using the sVEP technique. Neonatal history was tracked prospectively for predischarge TB, use of phototherapy, exposure to anesthesia (none), heart disease (excluded), and thyroid dysfunction. Infants were divided into 4 quartiles, based on their hour-specific TB level. Infants in each quartile were compared to their average acuity thresholds at 6 and 12 mos of age.

Results: TB levels ranged from 0.5-21.6 mg/dL (median 7.9). CS and VA (p<0.05 for 6 and 12 mos) were significantly correlated to TB levels overall, but the effect was most pronounced in infants in the top quartile at both 6 and 12 mo of age; i.e., those who have the highest for BIND. GA was not affected by TB level.<br />

Conclusions: A reduction in visual sensitivity occurs at 6 mos and persists to 12 mos of age, and correlates with the level of TB in the newborn period for CS and VA measures. Infants whose TB levels were in the highest (4th) quartile on the Bhutani nomogram were significantly more likely to have reductions in visual sensitivity compared to infants in the lower 3 quartiles. These findings suggest that a strategy for managing neonatal jaundice, and for potentially preventing BIND, at least in regards to the visual cortex and related functions.<br />

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×